These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21062114)

  • 21. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
    Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N
    Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine.
    McKenna DH; Adams S; Sumstad D; Sumstad T; Kadidlo D; Gee AP; Durett A; Griffin D; Donnenberg A; Amrani D; Livingston D; Lindblad R; Wood D; Styers D
    Cytotherapy; 2010 Apr; 12(2):170-7. PubMed ID: 20078385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield.
    Hildebrandt M; Serke S; Meyer O; Ebell W; Salama A
    Transfusion; 2000 May; 40(5):507-12. PubMed ID: 10827251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
    Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
    Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts.
    O'Donnell PV; Myers B; Edwards J; Loper K; Rhubart P; Noga SJ
    Cytotherapy; 2001; 3(6):483-8. PubMed ID: 11953032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
    Robinson SN; Freedman AS; Neuberg DS; Nadler LM; Mauch PM
    Exp Hematol; 2000 Dec; 28(12):1325-33. PubMed ID: 11146154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
    Lanza F; Campioni D; Moretti S; Dominici M; Punturieri M; Focarile E; Pauli S; Dabusti M; Tieghi A; Bacilieri M; Scapoli C; De Angeli C; Galluccio L; Castoldi G
    Exp Hematol; 2001 Dec; 29(12):1484-93. PubMed ID: 11750108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.
    Shpall EJ; LeMaistre CF; Holland K; Ball E; Jones RB; Saral R; Jacobs C; Heimfeld S; Berenson R; Champlin R
    Blood; 1997 Dec; 90(11):4313-20. PubMed ID: 9373242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.
    Ogura M; Kagami Y; Suzuki R; Miura K; Uehira K; Kurokawa T; Ito T; Kinoshita T; Emi N; Morishima Y; Kodera Y; Ueda R
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S51-7. PubMed ID: 9272135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired stem cell function of CD34+ cells selected by two different immunomagnetic beads systems.
    Kimura T; Minamiguchi H; Wang J; Kaneko H; Nakagawa H; Fujii H; Sonoda Y
    Leukemia; 2004 Mar; 18(3):566-74. PubMed ID: 14712284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer.
    Preti RA; Lazarus HM; Winter J; Stadtmauer EA; Nadasi S; McMannis J; Karandish S; Jennis A; Goldberg SL; Pecora AL
    Cytotherapy; 2001; 3(2):85-95. PubMed ID: 12028831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of leukapheresis cell composition on immunomagnetic cell selection with the Baxter Isolex 300i device: a statistical analysis.
    Perotti C; Del Fante C; Viarengo GL; Bergamaschi P; Tinelli C; Bellotti L; Marchesi A; Parisi C; Salvaneschi L
    Stem Cells Dev; 2004 Aug; 13(4):350-6. PubMed ID: 15345128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems.
    Paulus U; Dreger P; Viehmann K; von Neuhoff N; Schmitz N
    Stem Cells; 1997; 15(4):297-304. PubMed ID: 9253114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
    Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study.
    Lemoli RM; Martinelli G; Olivieri A; Motta MR; Rizzi S; Terragna C; Leopardi G; Benni M; Ronconi S; Cantori I; Rondelli D; Mangianti S; Leoni P; Montanari M; Cavo M; Tura S
    Br J Haematol; 1999 Nov; 107(2):419-28. PubMed ID: 10583236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
    Han X; Shi Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel and feasible way to cultivate and purify endothelial progenitor cells from bone marrow of children with congenital heart diseases.
    Wu YT; Li JX; Liu S; Xin Y; Wang ZJ; Gao J; Ji BY; Fan XM; Zhou QW
    Chin Med J (Engl); 2012 Jun; 125(11):1903-7. PubMed ID: 22884051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The diversity of human hematopoietic stem/progenitor cells. I. Two-color flow cytometric analysis of the different functional subpopulations of CD 34+ hematopoietic stem/progenitor cells riched from human bone marrow].
    Xi YZ; Zhang SX; Tang PH; Wei W; Kong FH
    Shi Yan Sheng Wu Xue Bao; 1996 Mar; 29(1):49-57. PubMed ID: 9208642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.